Search Count: 5
 |
Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) In Complex With An Inhibitor Meds765
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2024-08-21 Classification: OXIDOREDUCTASE Ligands: NAP, A1ICG, EDO, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-08-21
Ligands: NAP, A1ICG, EDO, MES
 |
Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) In Complex With An Inhibitor M689, With The 3-Hydroxy-Benzoisoxazole Moiety. Resolution 2.0A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-03-06 Classification: OXIDOREDUCTASE Ligands: NAP, YMC, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-03-06
Ligands: NAP, YMC, EDO
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-05-08
Ligands: NAP, FFW, EDO
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: NAP, CJ2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: NAP, CJ2
 |
Potent And Selective Aldo-Keto Reductase 1C3 (Akr1C3) Inhibitors Based On The Benzoisoxazole Moiety: Application Of A Bioisosteric Scaffold Hopping Approach To Flufenamic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2018-04-04 Classification: OXIDOREDUCTASE Ligands: CVN, CL, NAP |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-04-04
Ligands: CVN, CL, NAP